Albert Jude Manifold - Mar 3, 2025 Form 4 Insider Report for CRH PUBLIC LTD CO (CRH)

Signature
/s/ Neil Colgan, Attorney-in-fact for Albert Jude Manifold
Stock symbol
CRH
Transactions as of
Mar 3, 2025
Transactions value $
-$11,985,461
Form type
4
Date filed
3/5/2025, 04:30 PM
Previous filing
Mar 4, 2025
Next filing
May 27, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRH Ordinary Shares Award $0 +198K +247.23% $0.00 278K Mar 3, 2025 Direct F1
transaction CRH Ordinary Shares Options Exercise $0 +25.9K +9.33% $0.00 304K Mar 3, 2025 Direct F2
transaction CRH Ordinary Shares Tax liability -$12M -116K -38.3% $102.93 188K Mar 3, 2025 Direct F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Albert Jude Manifold is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Reflects the vesting and release of awards granted in 2020 under the 2014 Performance Share Plan Rules on March 3, 2025 (including the award of 25,484 additional Ordinary Shares as dividend equivalents), pursuant to certification of the achievement of pre-established performance goals by the Compensation Committee of the Board of Directors of the Issuer (the "Compensation Committee").
F2 Reflects the vesting and release of a 2022 time-based conditional award as defined in the 2014 Deferred Share Bonus Plan (the "DSB Plan Rules"), of which, pursuant to the determination of the Compensation Committee, a total of 25,942 shares vested on March 3, 2025, including the award of 2,172 additional Ordinary Shares as dividend equivalents.
F3 Mandatory sale of sufficient Ordinary Shares to cover applicable withholding tax liabilities arising in connection with the aforementioned award.
F4 The reported price represents the volume-weighted average price of shares sold. Sale prices for the reported transaction ranged between $102.30 and $103.535 inclusive of shares sold on the New York Stock Exchange. Full information regarding the number of Ordinary Shares sold at each separate price in the range will be provided to the SEC upon request.
F5 The Reporting Person retired from his position as Chief Executive Officer and as a member of the Board of Directors of the Issuer, effective December 31, 2024, and therefore a Form 3 was not filed in connection with the Issuer's transition to U.S. domestic issuer reporting status, effective January 1, 2025.

Remarks:

Former Executive Officer & Director